Search Results - "INSULL, W"

The problem of compliance to cholesterol altering therapy by INSULL, W.

“…This review's purpose is to describe for the practicing clinician the current knowledge about patient compliance to cholesterol‐altering drugs and about…”
Get full text

A definition of initial, fatty streak, and intermediate lesions of atherosclerosis : a report from the committee on vascular lesions of the council on arteriosclerosis American heart association by STARY, H. C, CHANDLER, C. A. B, GLAGOV, S, GUYTON, J. R, INSULL, W. JR, ROSENFELD, M. E, SCHAFFER, S. A, SCHWARTZ, C. J, WAGNER, W. D, WISSLER, R. W

“…The compositions of lesion types that precede and that may initiate the development of advanced atherosclerotic lesions are described and the possible…”
Get full text

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis : a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association by STARY, H. C, CHANDLER, A. B, DINSMORE, R. E, FUSTER, V, GLAGOV, S, INSULL, W. JR, ROSENFELD, M. E, SCHWARTZ, C. J, WAGNER, W. D, WISSLER, R. W

“…This report is the continuation of two earlier reports that defined human arterial intima and precursors of advanced atherosclerotic lesions in humans. This…”
Get full text

Levels of soluble cell adhesion molecules in patients with dyslipidemia by HACKMAN, A, ABE, Y, INSULL, W. JR, POWNALL, H, SMITH, L, DUNN, K, GOTTO, A. M, BALLANTYNE, C. M

“…Increased expression of cell adhesion molecules (CAMs) on the vascular endothelium has been postulated to play an important role in atherogenesis. Both in…”
Get full text

A definition of the intima of human arteries and of its atherosclerosis-prone regions : a report from the committee on vascular lesions of the council on arteriosclerosis, american heart association by STARY, H. C, BLANKENHORN, D. H, WISSLER, R. W, CHANDLER, A. B, GLAGOV, S, INSULL, W. JR, RICHARDSON, M, ROSENFELD, M. E, SCHAFFER, S. A, SCHWARTZ, C. J, WAGNER, W. D

Get full text

Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively by Hunninghake, Donald, Insull, William, Toth, Phillip, Davidson, David, Donovan, Joanne M, Burke, Steven K

“…Colesevelam hydrochloride is a novel, potent, non-absorbed lipid-lowering agent previously shown to reduce low density lipoprotein (LDL) cholesterol. To…”
Get full text

A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis: A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association by Stary, Herbert C, Chandler, A. Bleakley, Dinsmore, Robert E, Fuster, Valentin, Glagov, Seymour, Insull, Jr, Rosenfeld, Michael E, Schwartz, Colin J, Wagner, William D, Wissler, Robert W

“…This report is the continuation of two earlier reports that defined human arterial intima and precursors of advanced atherosclerotic lesions in humans. This…”
Get full text

Effect of dietary cholesterol on cholesterol synthesis in breast-fed and formula-fed infants by WONG, W. W, HACHEY, D. L, INSULL, W, OPEKUN, A. R, KLEIN, P. D

“…The fractional synthesis rate (FSR) of cholesterol was measured in 6 breast-fed and 12 formula-fed infants (ages 4 to 5 months) using the 2H2O method. The…”
Get full text

Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial by Insull, Jr, W, Toth, P, Mullican, W, Hunninghake, D, Burke, S, Donovan, J M, Davidson, M H

“…To evaluate the efficacy, tolerability, and safety of colesevelam hydrochloride, a new nonsystemic lipid-lowering agent. In this double-blind,…”
Get more information

Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: The Pivotal Placebo-Controlled Clinical Trial by Insull, W, Isaacsohn, J, Kwiterovich, P, Ma, P, Brazg, R, Dujovne, C, Shan, M, Shugrue-Crowley, E, Ripa, S, Tota, R

“…This pivotal, multicentre, double-blind, parallel-group study evaluated the efficacy and safety of cerivastatin 0.8 mg. Patients with primary…”
Get full text

A definition of initial, fatty streak, and intermediate lesions of atherosclerosis : a report from the Committee on vascular lesions of the council on arteriosclerosis, American Heart Association by STARY, H. C, CHANDLER, A. B, GLAGOV, S, GUYTON, J. R, INSULL, W. JR, ROSENFELD, M. E, SCHAFFER, S. A, SCHWARTZ, C. J, WAGNER, W. D, WISSLER, R. W

“…The compositions of lesion types that precede and that may initiate the development of advanced atherosclerotic lesions are described and the possible…”
Get full text

Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia by Insull, William, Koren, Michael, Davignon, Jean, Sprecher, Dennis, Schrott, Helmut, Keilson, Leonard M, Brown, Alan S, Dujovne, Carlos A, Davidson, Michael H, McLain, Richard, Heinonen, Therese

“…Although acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors have been shown to reduce lipid levels in several animal models, the safety and lipid modifying…”
Get full text

Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia by Davidson, M H, Stein, E A, Hunninghake, D B, Ose, L, Dujovne, C A, Insull, Jr, W, Bertolami, M, Weiss, S R, Kastelein, J J, Scott, R S, Campodónico, S, Escobar, I D, Schrott, H G, Bays, H, Stepanavage, M E, Wu, M, Tate, A C, Melino, M R, Kush, D, Mercuri, M, Mitchel, Y B

“…Clinical data suggesting that larger decreases in low density lipoprotein cholesterol (LDL-C) result in greater reductions in coronary heart disease events…”
Get more information

Long‐Term Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Primary Hypercholesterolemia by Isaacsohn, Jonathan, Insull, William, Stein, Evan, Kwiterovich, Peter, Patrick, Ma, Brazg, Ronald, Dujovne, Carlos A., Shan, Michael, Shugrue‐Crowley, Elizabeth, Ripa, Steven, Tota, Robert

“…Background: Statins are the agents of choice in reducing elevated plasma low‐density lipoprotein cholesterol (LDL‐C). Hypothesis: Cerivastatin 0.8 mg has…”
Get full text

Maintenance of a low-fat diet: follow-up of the Women's Health Trial by E White, A L Shattuck, A R Kristal, N Urban, R L Prentice, M M Henderson, W Insull, Jr, M Moskowitz, S Goldman, M N Woods

“…This report examines the maintenance of a low-fat diet 1 year on average after the completion of intervention sessions among participants in the Women's Health…”
Get full text

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study by Hunninghake, D B, Knopp, R H, Schonfeld, G, Goldberg, A C, Brown, W V, Schaefer, E J, Margolis, S, Dobs, A S, Mellies, M J, Insull, Jr, W

“…This multicenter, double-blind, placebo-controlled, dose-response study was conducted in patients with primary hypercholesterolemia to examine the effects of…”
Get more information

Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management by CHLEBOWSKI, R. T, ROSE, D, BUZZARD, I. M, BLACKBURN, G. L, INSULL, W. JR, GROSVENOR, M, ELASHOFF, R, WYNDER, E. L

Get full text

Clinical efficacy and safety of cerivastatin: summary of pivotal Phase IIb/III studies by Davignon, Jean, Hanefeld, Markolf, Nakaya, Noriaki, Hunninghake, Donald B, Insull, William, Ose, Leiv

“…Cerivastatin is a new, third-generation 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor (“statin”), which is administered to…”
Get full text

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing by Hunninghake, D B, Mellies, M J, Goldberg, A C, Kuo, P T, Kostis, J B, Schrott, H G, Insull, Jr, W, Pan, H Y

“…This 8-week multicenter, placebo-controlled trial compared the efficacy and safety of the HMG-CoA reductase inhibitor, pravastatin, when administered either as…”
Get more information

Plasma lipid effects of three common vegetable oils in reduced-fat diets of free-living adults by Insull, W, Silvers, A, Hicks, L, Probstfield, JL

“…We compared plasma lipid changes due to the polyunsaturated fatty acids (PUFAs) in partially hydrogenated soybean oil, corn oil, and sunflower oil fed in…”
Get full text